Denver-based Baxa Corporation announces the signing of an exclusive co-marketing agreement with Unit Dose Solutions Inc. of Morrisville, NC. Under the agreement, Baxa will market and sell the oral unit dose repackaging services provided by Unit Dose Solutions. UDS serves hospital and alternate-care providers by offering an outsourcing alternative for unit dose packaging and labeling. - September 22, 2006 - Baxa Corporation - Featured Press Release

The anti-VEGF Fab Lucentis is the new standard of care to treat AMD because it can improve visual acuity. Competitor drugs directed against the same and innovative targets are applied with non-intravitreal forms of administration to avoid the unease of intra-vitreal injection. - September 20, 2006 - La Merie Business Intelligence

InViragen, LLC, a biotechnology company dedicated to developing vaccines for emerging infectious diseases worldwide, has entered into an Exclusive Patent License Agreement with the Centers for Disease Control and Prevention (CDC). The licensed technology is applicable to vaccines against multiple viral diseases, including dengue fever and West Nile disease. Dengue fever threatens 2.5 billion people worldwide as well as travelers to tropical countries. - September 14, 2006 - Colorado BioScience Association - Featured Press Release

Baxa Ltd, subsidiary of Denver-based Baxa Corporation, has moved to a direct sales and marketing model for the Austrian market. The company provides systems and devices for simplifying the handling, mixing and administration of fluid medications. Direct operations will provide Baxa Ltd with improved customer access for product development and continuous improvement, while continuing their excellent customer service. - September 12, 2006 - Baxa Corporation - Featured Press Release

Anti-TNF agents set the new gold standard of psoriasis treatment which could be outperformed by smarter next generation biologics and small molecules in safety and convenience. - September 08, 2006 - La Merie Business Intelligence

Five Colorado-based companies have been selected to present at the Biotechnology Industry Organization (BIO) Mid-America VentureForum to be held September 25-27th at the InterContinental Hotel in Cleveland, Ohio. These companies are among more then 50 companies selected by venture capitalists from the nation’s leading firms who serve on BIO’s advisory board. - September 07, 2006 - Colorado BioScience Association - Featured Press Release

New Life Scientific, Inc (NWLS) a developmental biotech company whose core focus is to develop and commercialize novel biotech/pharmaceutical products including vaccines and stem cell based treatment modalities and to expand through our own research, collaborations, acquisitions and in-licensing, announced... - September 01, 2006 - New Life Scientific, Inc.

Gamma Medica-Ideas (GM-I) will unveil its new FLEX Triumph™ tri-modality pre-clinical imaging system at the Society of Molecular Imaging’s annual meeting in Hawaii this week. FLEX Triumph is GM-I’s fifth generation pre-clinical imaging system. It can be configured with PET, SPECT,... - August 31, 2006 - Gamma Medica-Ideas

ApopLogic Pharmaceuticals has won the second annual Faegre & Benson Venture Showcase Award at the BioWest 2006 conference in Denver. The announcement is made by Chris Shapard, bioscience director at the Colorado Office of Economic Development and International Trade (OEDIT), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards banquet held Thurs. evening at the Colo. Convention Center. - August 25, 2006 - Colorado BioScience Association - Featured Press Release

Baxa Corporation is holding a ribbon-cutting ceremony today for a new, first-in-the-industry, strategic training center. The STAR Center offers pharmacy training for peak performance. First classes begin September 20th at the Englewood, Colo., location.. The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn. - August 23, 2006 - Baxa Corporation - Featured Press Release

The Colorado BioScience Association (CBSA) has released winners of its 2006 Awards Program. Official presentation of the awards occurs Thursday evening, August 24, 6:30 – 8:30 p.m., at the CBSA’s annual awards banquet. Held in conjunction with the 2006 BioWest conference at the Colorado Convention Center, registration information is available at the 2006 BioWest Conference website. - August 18, 2006 - Colorado BioScience Association - Featured Press Release

The versatility of the vascular endothelial growth factor (VEGF) signalling pathway as a validated target and its excellent tractability explain a crowded field of drugs of all classes. - August 17, 2006 - La Merie Business Intelligence

Blue Sky Biotech, Inc. announced the June 1st appointment of Scott Gridley, Ph.D., as Senior Research Scientist. Dr. Gridley previously worked for five years in the metabolic diseases division of Sandoz Research Institute (now Novartis Institutes for BioMedical Research) where he was involved in the... - August 15, 2006 - Blue Sky Biotech, Inc.

Claude Hooton, Executive Vice President of Sales and Marketing for Baxa Corporation was recognized for his leadership through his contribution to the recently released book, Inside the Minds: The Health Care Management Team. Hooton’s contribution joins those of CEOs, CTOs and other leaders to provide insight into the best leadership practice in the health care industry. - August 11, 2006 - Baxa Corporation - Featured Press Release

The new version of Abacus, the specialized Baxa software for managing orders and calculations for total parenteral nutrition, is now available. The Windows-based system is the industry-leading program for automated compounding. Designed by health-system pharmacists, Abacus v2 ensures safety and reduces the opportunity for user error in the prescribing, calculating and mixing of multi-source compounds. - August 09, 2006 - Baxa Corporation - Featured Press Release

In a ceremony held today in Westminster, Colorado – Englewood-based Baxa Corporation was selected in second place for best large company to work for in Colorado. Candidate choice followed finalist selection based on employee surveys by the Society for Human Resource Management. - August 03, 2006 - Baxa Corporation - Featured Press Release

The US$ 7.6 bln market of TNF-antagonists attracts numerous follow-on compounds including improved TNF-antagonists and molecules originating from new technologies. - August 02, 2006 - La Merie Business Intelligence

CEOs from five of Colorado’s top bioscience companies will present at the BioWest 2006 Investor Forum on August 24th – registration is still open for the two-day BioWest event, which is the Rocky Mountain Region’s premier bioscience conference and expo. CEOs featured in the Investor Forum include Paul Berns, Allos Therapeutics; John Serino, Encision; Bill Freytag, Myogen; Patrick Mahaffy, Pharmion; and Ken Collins, Replidyne. - July 28, 2006 - Colorado BioScience Association - Featured Press Release

CytoCore, Inc., a biomolecular diagnostics screening company committed to bringing new cancer solutions to the market, has announced the development of a new screening and treatment system. CytoCore has developed the InPath™ System, a cervical/uterine cancer screening and treatment system that... - July 24, 2006 - CytoCore

Englewood-based Baxa Corporation has been selected one of the 25 best companies to work for in Colorado following employee surveys by the Society for Human Resource Management (SHRM). The recognition is a result of the responses received from an electronic survey sent to most of the company’s Colorado-based associates in April. The Best Companies initiative honors Colorado companies that show dedication to their employees’ growth and quality of life. - July 21, 2006 - Baxa Corporation - Featured Press Release

Medical Device and Diagnostic Industry (MD&DI) magazine has selected Colorado-based Baxa Corporation as a notable company in its review of medical device manufacturers and their contributions The magazine chose companies with formidable track records or the potential for success, and technology breakthroughs or transformations of standards of care that its editors feel are worth monitoring. This is the first year that Baxa has won this designation. - July 14, 2006 - Baxa Corporation - Featured Press Release

Novel cancer drugs; innovative treatments for blood cancers and clotting; new ways to attack inflammatory and infectious diseases; ground-breaking compounds to treat osteoporosis and metastatic bone disease; pioneering devices for orthopedic surgery; commercializing biofuels from algae; and revolutionary wearable rehabilitation systems comprise the seven finalists in this year’s BioWest Veture Showcase competition. - July 11, 2006 - Colorado BioScience Association - Featured Press Release

EarthPulse™ enhances athletic performance in world class and amateur competitors safely and more effectively than anabolic steroids or blood doping, while significantly improving their sleep. - July 09, 2006 - EarthPulse Technologies, LLC

Raleigh PR firm to provide public relations and product marketing services to Uterine and Cervical Cancer screening firm. - July 08, 2006 - CytoCore

Baxa introduces a new 4 mm version of its CyTwo-Fer Needle. The unique dual-purpose device permits vented and non-vented use for vial reconstitution and withdrawal from drug vials and bags. - June 26, 2006 - Baxa Corporation - Featured Press Release

Baxa Corporation demonstrates the next-generation ValiMed System for medication safety at booth no. 729 at the American Society of Health-System Pharmacists Summer Meeting June 25 – 28 in Orlando, Fla. The next-generation ValiMed Technology offers the same benefits as the original system, with additional reporting features and a smaller sample requirement. - June 26, 2006 - Baxa Corporation - Featured Press Release

Baxa Corporation will announce the development of a professional Skills Training, Academics and Resources (STAR) Center for pharmacy and cleanroom skills training at the Annual Meeting of the American Society of Health-System Pharmacists in Orlando, Florida. The STAR Center, a state-of-the-art facility designed for cleanroom and pharmacy practice demonstration, is located at the company’s world headquarters south of Denver, Colorado. - June 23, 2006 - Baxa Corporation - Featured Press Release

The US$ 32 bln market of six major protein products is enfacing competition by less costly biogenerics and by improved products via drug delivery or protein engineering technologies and even oral, small molecule solutions. - June 20, 2006 - La Merie Business Intelligence

Healthcare professional, Stacey Lloyd, is offering a free webinar to discuss the risks of contracting tuberculosis during air travel at www.StaceyLloyd.com. This webinar will be available to air travelers and healthcare personnel during the busy travel season. - June 20, 2006 - Pharmaceutical Resources Group

New size of Exacta-Med® Oral Dispenser completes the product range – from 0.5 to 60 mL – of safe oral medication dispensers for market leader Baxa Corporation. Exacta-Med Oral Dispensers play a vital role in preventing wrong-route administration of non-IV fluid drugs. Their unique dispenser tip cannot connect to a luer needle hub or a needleless IV system. - June 13, 2006 - Baxa Corporation - Featured Press Release

Registration is now open for the Rocky Mountain Region’s Premier Bioscience Conference and Expo, BioWest 2006. More than 750 participants are expected at this year’s event, August 23-24, at the Colorado Convention Center in Denver. America’s “Cowboy Poet” Baxter Black and NPR Science Friday® host Ira Flatow are the headliners for Biowest 2006, along with the presentation, “Where Innovation Happens” from Federal Reserve Executive Michael Orlando. - June 06, 2006 - Colorado BioScience Association - Featured Press Release

Cornerstone BioPharma™, the Triangle-based specialty pharmaceutical company currently focused on the development and commercialization of niche prescription medications in the respiratory arena, today announced the company has signed a co-promotion agreement with Athlon Pharmaceuticals (Athlon).... - June 06, 2006 - Cornerstone BioPharma

AnaSpec, a leading provider of integrated proteomics solutions, has introduced an extensive new line of reagents and kits for the study of protein phosphorylation. Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that serves to modify the activity of the phosphorylated... - June 06, 2006 - AnaSpec, Inc.

At the Colorado American Marketing Association PEAK Awards ceremony, Baxa Corporation won the Gold Award for Direct Mail Campaign and the Annual Marketer of the Year Award. The direct mail award recognized the success of the company’s Real Pharmacy campaign, developed to generate customer testimonials for Baxa products. Marian Robinson, VP of Marketing for Baxa Corporation was recognized as Annual Marketer of the Year (AMY) for exemplifying outstanding marketing leadership and accomplishment. - June 05, 2006 - Baxa Corporation - Featured Press Release

The Business Intelligence firm La Merie S.L. reported today changes in the field of erythropoiesis stimulating agents (ESA) observed in a follow-up analysis. The first launch of a new ESA in Europe is expected to be Shire’s epoetin omega in the first half of 2007 to be followed by Roche’s... - June 03, 2006 - La Merie Business Intelligence

The Localized delivery of phosphodiesterase-4 (PDE-4) inhibitors appears to be short term solution to overcome the dose-limiting side effects of severe nausea and emesis occurring after oral administration. In the long-term, subtype-selective PDE-4 inhibitors and combination regimens may help to improve the therapeutic index. - May 31, 2006 - La Merie Business Intelligence

BioTX has finished the development of an application based, light guided manual pipetting system called WellAware which is ideal for forensic, paternity, life science, pharmaceutical, preclinical and chemistry labs. WellAware provides lab managers with an inexpensive alternative or supplement to full automation. WellAware is configured right out of the box for PCR, DNA sequencing, genotyping, microplate transpositions, dilutions, normalizations, microplate reformatting and cherry-picking. - May 25, 2006 - BioTX Automation, Inc.

The interferon alpha market is smaller than the interferon beta market, but is characterized by far more products and R&D projects. Conversion of the interferon alpha market to pegylated products explains why new R&D is focused on interferon alpha variants or other subtypes with improved pharmacodynamic and safety properties. - May 19, 2006 - La Merie Business Intelligence

Colorado-based pharmacy products manufacturer, Baxa Corporation now has a CD available of the presentation, 'What’s Next with USP 797?' from the annual American Society of Health-System Pharmacists Midyear Clinical Meeting in Las Vegas. Eric Kastango, MBA, RPh, discussed the proposed changes to the USP 797 guidelines for sterile compounding and the impact on the hospital pharmacy practice. - May 10, 2006 - Baxa Corporation - Featured Press Release

The Business Intelligence firm La Merie S.L. reported today that the RNAi therapeutic pipeline is rapidly filling and advancing towards clinical development. Four RNAi therapeutic projects are in early clinical development. At least 32 RNAi projects are in preclinical development in a variety of therapeutic... - May 10, 2006 - La Merie Business Intelligence

BioWest, The Rocky Mountain Region’s Premier Bioscience Conference and Expo, is again looking for the best bioscience start-ups in the region as candidates for the $10,000 Faegre & Benson Venture Showcase Award. Seven companies will be chosen to present at the Showcase in August, which will be judged by a panel of national venture capitalists. Deadline for entry is June 8, 2006. - May 09, 2006 - Colorado BioScience Association - Featured Press Release

Freathy Brings Experience in Pharmaceutical Compliance and Quality Assurance to the Network. - May 04, 2006 - Pharmaceutical Resources Group

Baxa Corporation has met the requirements for management systems conformity under the British Standards Institution for ISO-13485:2003. The company recently named BSI as its new registrar and completed its first official assessment with them. Previously, Baxa Corporation’s US and UK operations used different auditors for ISO and CE compliance. Under BSI, the company now has a single world-class auditor for both facilities. - May 03, 2006 - Baxa Corporation - Featured Press Release

One night of EarthPulse® very weak pulsed electromagnetic field (PEMF) raises saturated blood oxygen 3%, inhalation volume 6% and breath-hold duration 7% in asthmatic American record holder. - April 28, 2006 - EarthPulse Technologies, LLC

Baxa Corporation, Denver-based manufacturer of medical devices for healthcare systems, has won a 2006 Business Marketing Association Gold Key Award. The winning entry was the Baxa “One Less Thing” campaign, which promoted the safety and ease-of-use of the Exacta-Med® Oral Dispensers. The Baxa oral dispensers were the company’s first product, and still contribute greater than 30% of its revenues today. - April 27, 2006 - Baxa Corporation - Featured Press Release

Seven new appointments were made to the Board of Directors of Colorado BioScience Association at its 2006 Annual Membership Meeting, along with eight reappointments. In addition, the 2006 Corporate Sponsors were released; Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award; and the 2006-2007 Bioscience Colorado Magazine was unveiled to members at the event. - April 18, 2006 - Colorado BioScience Association - Featured Press Release

Colorado BioScience Association released new 76-page issue of Bioscience Colorado Magazine at the 2006 Annual Membership Meeting. In addition, seven new appointments were made to the Board of Directors, along with eight reappointments; 2006 Corporate Sponsors were introduced; and Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award. - April 18, 2006 - Colorado BioScience Association - Featured Press Release

Brandon Shaffer, Colorado State Senator District 17, was presented the national Biotechnology Industry Organization Legislator of the Year Award at the Colorado BioScience Association 2006 Annual Membership Meeting. The award was presented by Amgen Colorado’s Eric Bergenson. Senator Shaffer was singled out nationally for his ongoing and extensive support of the bioscience industry in the state. - April 18, 2006 - Colorado BioScience Association - Featured Press Release

Two campaigns designed and executed by the Baxa in-house design team have been selected for 2006 American Inhouse Design Awards for creative work on a recent direct mail campaign (‘right equipment’) and a national customer promotion (‘real pharmacy’). Graphic Design USA – a national magazine for design professionals – has sponsored design competitions for four decades. The 2006 winners were chosen from nearly 3,500 submissions, less than 20% of which received awards. - April 13, 2006 - Baxa Corporation - Featured Press Release

EarthPulse Technologies, LLC develops PEMF agriculture application capable of substantially cutting germination time and increasing growth rate of sprouted seeds and beans, proving that directed magnetic field forces can increase yield by weight over 90%. - April 11, 2006 - EarthPulse Technologies, LLC